 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Assembly Biosciences
ASMB
|
4.27 |
$ 28.46 |
- |
$ 319 M |
USA |
 |
Ascendis Pharma A/S
ASND
|
947 |
$ 221.88 |
- |
$ 5 B |
Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.29 |
- |
$ 7.92 B |
Australia |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K |
$ 1.37 |
- |
$ 350 M |
Britain |
 |
Axsome Therapeutics
AXSM
|
13.6 |
$ 156.92 |
- |
$ 7.81 B |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
BioMarin Pharmaceutical
BMRN
|
3.63 |
$ 54.13 |
- |
$ 10.4 B |
USA |
 |
Benitec Biopharma
BNTC
|
54.5 |
$ 10.98 |
- |
$ 452 M |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 7.7 |
- |
$ 1.31 B |
Britain |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Compugen Ltd.
CGEN
|
49.8 |
$ 2.09 |
- |
$ 195 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
AbCellera Biologics
ABCL
|
12.8 |
$ 3.4 |
- |
$ 1.02 B |
Canada |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Calithera Biosciences
CALA
|
98.5 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Cara Therapeutics
CARA
|
2.58 |
- |
-3.03 % |
$ 260 M |
USA |
 |
ChemoCentryx
CCXI
|
0.0564 |
- |
- |
$ 3.74 B |
USA |
 |
Coherus BioSciences
CHRS
|
5.36 |
$ 1.52 |
- |
$ 178 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
3.91 K |
- |
- |
$ 169 M |
USA |
 |
Clovis Oncology
CLVS
|
1.55 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
2.86 |
$ 8.6 |
- |
$ 115 M |
USA |
 |
Curis
CRIS
|
1.21 |
$ 0.77 |
- |
$ 4.86 M |
USA |
 |
Cellectis S.A.
CLLS
|
6.69 |
$ 3.34 |
- |
$ 116 M |
France |
 |
Arbutus Biopharma Corporation
ABUS
|
24.5 |
$ 4.24 |
- |
$ 704 M |
Canada |
 |
AIkido Pharma
AIKI
|
1.08 |
- |
1.93 % |
$ 17.4 M |
USA |